Dual Role of Circulating Angiopoietin-Like 4 (ANGPTL4) in Promoting Hypertriglyceridemia and Lowering Proteinuria in Nephrotic Syndrome

American Journal of Kidney Diseases

Volumn 64, Issue 4, 2014, Pages 495-498

  Vaziri, Nosratola D ^a   Moradi, Hamid ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 4; UNCLASSIFIED DRUG;

FATTY ACID TRANSPORT; HUMAN; HYPERTRIGLYCERIDEMIA; NEPHROTIC SYNDROME; NONHUMAN; NOTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEINURIA; ANIMAL; BLOOD; FEEDBACK SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOPOIETINS; ANIMALS; FEEDBACK, PHYSIOLOGICAL; HUMANS; HYPERTRIGLYCERIDEMIA; NEPHROTIC SYNDROME; PROTEINURIA;

EID: 84908137879     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.04.016     Document Type: Editorial

References (35)

1. J. Joven, C. Villabona, E. Vilella, L. Masana, R. Albertí, and M. Vallés Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome N Engl J Med 323 9 1990 579 584
2. G.A. Kaysen, and M.G. de Sain-van der Velden New insights into lipid metabolism in the nephrotic syndrome Kidney Int Suppl 71 1999 S18 S21
3. N.D. Vaziri Molecular mechanisms of lipid disorders in nephrotic syndrome Kidney Int 63 2003 1964 1976
4. L.C. Clement, C. Macé, C. Avila-Casado, J.A. Joles, S. Kersten, and S.S. Chugh Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome Nat Med 20 2014 37 46
5. T. Sato, K. Liang, and N.D. Vaziri Downregulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis Kidney Int 61 2002 157 162
6. K. Liang, and N.D. Vaziri Gene expression of lipoprotein lipase in experimental nephrosis J Lab Clin Med 130 4 1997 387 394
7. N.D. Vaziri, J. Yuan, Z. Ni, S.B. Nicholas, and K.C. Norris Lipoprotein lipase deficiency in chronic kidney disease is compounded by downregulation of endothelial GPIHBP1 expression Clin Exp Nephrol 16 2012 238 243
8. K. Liang, and N.D. Vaziri Down-regulation of hepatic lipase expression in experimental nephrotic syndrome Kidney Int 51 6 1997 1933 1937
9. K. Liang, and N.D. Vaziri Acquired VLDL receptor deficiency in experimental nephrosis Kidney Int 51 1997 1761 1765
10. N.D. Vaziri, and K. Liang Downregulation of hepatic LDL receptor expression in experimental nephrosis Kidney Int 50 1996 887 893
11. N.D. Vaziri, T. Sato, and K. Liang Molecular mechanism of altered cholesterol metabolism in focal glomerulosclerosis Kidney Int 63 2003 1756 1763
12. K. Jin, B.S. Park, Y.W. Kim, and N.D. Vaziri Plasma PCSK9 in nephrotic syndrome and in peritoneal dialysis: a cross-sectional study Am J Kidney Dis 63 4 2014 584 589
13. N.D. Vaziri, K. Liang, and J.S. Parks Acquired lecithin: cholesterol acyltransferase (LCAT) deficiency in nephrotic syndrome Am J Physiol Renal Physiol 49 2001 F823 F829
14. K. Liang, and N.D. Vaziri Downregulation of hepatic high-density lipoprotein receptor, SR-B1 in nephrotic syndrome Kidney Int 56 1999 621 626
15. N.D. Vaziri, P. Gollapudi, S. Han, G. Farahmand, and H. Moradi Upregulation of hepatic HDL endocytic receptor and PDZK-1 dependent downregulation of HDL docking receptor in nephrotic syndrome Nephrol Dial Transplant 103 6 2011 524 533
16. S. Braschi, D. Masson, and G. Rostoker Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome Arterioscler Thromb Vasc Biol 17 11 1997 2559 2567
17. P. Moulin, G.B. Appel, H.N. Ginsberg, and A.R. Tall Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia J Lipid Res 33 12 1992 1817 1822
18. N.D. Vaziri, and K.H. Liang Upregulation of acyl-coenzyme A: cholesterol acyltransferase (ACAT) in nephrotic syndrome Kidney Int 61 2002 1769 1775
19. N.D. Vaziri, and K. Liang Acyl-CoA cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, LCAT, SRB-1 and LDL receptor deficiencies in nephrotic syndrome Circulation 110 2004 419 425
20. N.D. Vaziri, C. Kim, S. Kim, D. Phan, and K. Liang Upregulation of hepatic acyl CoA diglycerol acyltransferase (DGAT)-1 expression in nephrotic syndrome Kidney Int 66 2004 262 267
21. F. Kronenberg, A. Lingenhel, and K. Lhotta Lipoprotein(a) and low-density lipoprotein-derived cholesterol in nephrotic syndrome: impact on lipid-lowering therapy? Kidney Int 66 1 2004 348 354
22. L. Wang, G.C. Shearer, M.S. Budamagunta, J.C. Voss, A. Molfino, and G.A. Kaysen Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels Kidney Int 82 9 2012 990 999
23. P. Zhu, Y.Y. Goh, H.F. Chin, S. Kersten, and N.S. Tan Angiopoietin-like 4: a decade of research Biosci Rep 32 3 2012 211 219
24. B. Lu, A. Moser, J.K. Shigenaga, C. Grunfeld, and K.R. Feingold The acute phase response stimulates the expression of angiopoietin like protein 4 Biochem Biophys Res Commun 391 2010 1737 1741
25. W.K. Sonnenburg, D. Yu, and E.C. Lee GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4 J Lipid Res 50 2009 2421 2429
26. M.R. Robciuc, J. Naukkarinen, and A. Ortega-Alonso Serum angiopoietin-like 4 protein levels and expression in adipose tissue are inversely correlated with obesity in monozygotic twins J Lipid Res 52 2011 1575 1582
27. K. Kaddatz, T. Adhikary, F. Finkernagel, W. Meissner, S. Müller-Brüsselbach, and R. Müller Transcriptional profiling identifies functional interactions of TGFβ and PPARβ/δ signaling: synergistic induction of ANGPTL4 transcription J Biol Chem 285 2010 29469 29479
28. Y. Zuo, H.C. Yang, and S.A. Potthoff Protective effects of PPARgamma agonist in acute nephrotic syndrome Nephrol Dial Transplant 27 2012 174 181
29. H.C. Yang, L.J. Ma, J. Ma, and A.B. Fogo Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis Kidney Int 69 2006 1756 1764
30. L.C. Clement, C. Avila-Casado, and C. Mace Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome Nat Med 17 2011 117 122
31. S.S. Chugh, L.C. Clement, and C. Macé New insights into human minimal change disease: lessons from animal models Am J Kidney Dis 59 2012 284 292
32. L. Villa, P. Boor, and A. Konieczny Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis Nephrol Dial Transplant 26 2011 3131 3143
33. N.D. Vaziri Dyslipidemia of chronic renal failure: the nature, mechanisms and potential consequences Am J Physiol Renal Physiol 290 2006 262 272
34. N.D. Vaziri, and H. Moradi Mechanisms of dyslipidemia of chronic renal failure Hemodial Int 10 2006 1 7
35. T. Baranowski, S. Kralisch, and A. Bachmann Serum levels of the adipokine fasting-induced adipose factor/angiopoietin-like protein 4 depend on renal function Horm Metab Res 43 2011 117 120